Arcutis Biotherapeutics (ARQT) Institutional Ownership $15.98 +0.19 (+1.20%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$15.95 -0.03 (-0.18%) As of 08/22/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Arcutis Biotherapeutics (NASDAQ:ARQT)Number ofInstitutional Buyers(last 12 months)151TotalInstitutional Inflows(last 12 months)$337.52MNumber ofInstitutional Sellers(last 12 months)88TotalInstitutional Outflows(last 12 months)$195.68M Get ARQT Insider Trade Alerts Want to know when executives and insiders are buying or selling Arcutis Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ARQT Institutional Buying and Selling by Quarter Arcutis Biotherapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/19/2025 State of Wyoming12,398$174K0.0%-6.3%0.010% 8/15/2025 CANADA LIFE ASSURANCE Co25,829$363K0.0%+101.5%0.022% 8/15/2025 Tower Research Capital LLC TRC 12,414$174K0.0%+278.6%0.010% 8/15/2025 E Fund Management Co. Ltd.17,184$241K0.0%+14.7%0.014% 8/15/2025 Rafferty Asset Management LLC154,351$2.16M0.0%-3.8%0.129% 8/15/2025 Rubric Capital Management LP10,749,457$150.71M2.3%-2.0%8.965% 8/15/2025 Oxford Asset Management LLP23,271$326K0.1%+9.1%0.019% 8/15/2025 Lazard Asset Management LLC386,011$5.41M0.0%+3.2%0.322% 8/15/2025 Frazier Life Sciences Management L.P.9,874,511$138.44M5.5%+12.4%8.236% 8/15/2025 Gilder Gagnon Howe & Co. LLC4,155,763$58.26M0.6%+1.5%3.466% Get the Latest News and Ratings for ARQT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Arcutis Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/15/2025 Engineers Gate Manager LP97,605$1.37M0.0%+47.6%0.081% 8/15/2025 BNP Paribas Financial Markets11,653$163K0.0%+38.4%0.010% 8/15/2025 Brevan Howard Capital Management LP43,934$616K0.0%+8.2%0.037% 8/15/2025 Bellevue Group AG24,008$337K0.0%-32.8%0.020% 8/15/2025 Bank of America Corp DE1,202,513$16.86M0.0%+133.5%1.003% 8/15/2025 Ameriprise Financial Inc.99,044$1.39M0.0%-12.6%0.083% 8/15/2025 AQR Capital Management LLC375,233$5.26M0.0%+51.2%0.313% 8/14/2025 PDT Partners LLC190,983$2.68M0.2%-39.8%0.159% 8/14/2025 Raymond James Financial Inc.53,623$752K0.0%-7.6%0.045% 8/14/2025 Bayesian Capital Management LP13,900$195K0.0%N/A0.012% 8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.66,236$927K0.0%-7.3%0.055% 8/14/2025 Squarepoint Ops LLC167,814$2.35M0.0%+169.2%0.140% 8/14/2025 Sei Investments Co.12,099$170K0.0%-63.7%0.010% 8/14/2025 Stempoint Capital LP205,672$2.88M0.9%-61.9%0.172% 8/14/2025 Qube Research & Technologies Ltd577,493$8.10M0.0%+200.4%0.482% 8/14/2025 State Street Corp4,526,937$63.47M0.0%+1.2%3.775% 8/14/2025 Cerity Partners LLC18,660$262K0.0%-3.6%0.016% 8/13/2025 Jump Financial LLC14,562$204K0.0%-65.3%0.012% 8/13/2025 Diametric Capital LP38,858$545K0.3%+59.6%0.032% 8/13/2025 First Trust Advisors LP341,521$4.79M0.0%-22.4%0.285% 8/13/2025 Invesco Ltd.99,703$1.40M0.0%-92.5%0.083% 8/13/2025 Trek Financial LLC24,970$350K0.0%N/A0.021% 8/13/2025 Quantbot Technologies LP10,316$145K0.0%N/A0.009% 8/13/2025 Virtus Advisers LLC2,846$40K0.1%-75.5%0.002% 8/13/2025 Virtus Investment Advisers LLC6,965$98K0.0%-48.0%0.006% 8/13/2025 Tejara Capital Ltd873,381$12.25M5.7%+3.2%0.728% 8/13/2025 Norges Bank174,820$2.45M0.0%N/A0.146% 8/13/2025 Russell Investments Group Ltd.11,190$157K0.0%+4,562.5%0.009% 8/12/2025 Advisors Asset Management Inc.44,295$621K0.0%+57.1%0.037% 8/12/2025 XTX Topco Ltd37,555$527K0.0%-49.0%0.031% My #1 Pre IPO Trade for 2025 (Ad)SpaceX value has surged to $350 billion... Delivering windfall profits to early investors including Elon Musk and Peter Theil. Right now, you can invest in "the next SpaceX" while its valuation is still below $100 million.Just click here for details inside my free report8/12/2025 Prudential Financial Inc.598,900$8.40M0.0%+1.0%0.499% 8/12/2025 American Century Companies Inc.1,724,307$24.18M0.0%+4.3%1.438% 8/12/2025 Rhumbline Advisers186,099$2.61M0.0%+2.8%0.155% 8/12/2025 Franklin Resources Inc.2,732,777$38.31M0.0%-1.0%2.279% 8/12/2025 Legal & General Group Plc111,603$1.57M0.0%+3.7%0.093% 8/12/2025 JPMorgan Chase & Co.548,789$7.69M0.0%+1.0%0.458% 8/12/2025 DNB Asset Management AS28,171$395K0.0%N/A0.023% 8/12/2025 Ensign Peak Advisors Inc2,001,439$28.06M0.0%+0.7%1.669% 8/8/2025 Rockefeller Capital Management L.P.21,094$296K0.0%+14.3%0.018% 8/8/2025 Intech Investment Management LLC86,282$1.21M0.0%+23.8%0.072% 8/8/2025 Creative Planning19,575$274K0.0%+8.2%0.016% 8/8/2025 Candriam S.C.A.790,435$11.08M0.1%-23.7%0.663% 8/8/2025 Geode Capital Management LLC2,582,567$36.21M0.0%+1.4%2.167% 8/8/2025 PNC Financial Services Group Inc.8,828$124K0.0%+10.2%0.007% 8/8/2025 KBC Group NV3,055$43K0.0%-43.1%0.003% 8/8/2025 Jupiter Asset Management Ltd.412,738$5.79M0.0%N/A0.346% 8/7/2025 Simplify Asset Management Inc.409,432$5.74M0.3%-38.0%0.343% 8/7/2025 ProShare Advisors LLC26,414$370K0.0%-7.7%0.022% 8/7/2025 Profund Advisors LLC32,669$458K0.0%-3.2%0.027% 8/7/2025 Campbell & CO Investment Adviser LLC16,149$226K0.0%-78.5%0.014% 8/6/2025 Fox Run Management L.L.C.11,267$158K0.0%-62.4%0.009% 8/5/2025 Atlas Wealth LLC10,000$138K0.1%N/A0.008% 8/5/2025 Corton Capital Inc.16,943$238K0.3%N/A0.014% 8/1/2025 Jennison Associates LLC11,109,405$155.75M0.1%-2.2%9.320% 7/31/2025 AlphaQuest LLC11,921$167K0.0%+101.1%0.010% 7/30/2025 Privium Fund Management B.V.344,472$4.74M1.0%+5.8%0.289% 7/24/2025 Inspire Investing LLC28,772$403K0.0%+33.4%0.024% 7/24/2025 Aberdeen Group plc675,034$9.46M0.0%+14.9%0.566% 7/23/2025 KLP Kapitalforvaltning AS21,800$306K0.0%+17.8%0.018% 7/22/2025 Fishman Jay A Ltd. MI556,150$7.80M0.7%+4.3%0.467% 7/18/2025 AMI Asset Management Corp113,882$1.60M0.1%-45.4%0.096% 7/17/2025 LVW Advisors LLC17,561$246K0.0%+21.4%0.015% 7/16/2025 Signaturefd LLC2,137$30K0.0%-39.8%0.002% 7/10/2025 Wealth Enhancement Advisory Services LLC15,666$217K0.0%N/A0.013% 7/9/2025 Triumph Capital Management29,244$410K0.1%N/A0.025% 7/8/2025 Silverleafe Capital Partners LLC14,500$203K0.1%-44.7%0.012% 7/8/2025 GK Wealth Management LLC18,801$264K0.2%+28.2%0.016% 6/18/2025 Voya Investment Management LLC29,056$454K0.0%-9.6%0.024% 6/3/2025 Inspire Investing LLC21,570$337K0.0%-25.4%0.018% 6/3/2025Invst LLC20,652$323K0.0%N/A0.017% 5/29/2025 Rhumbline Advisers181,074$2.83M0.0%+7.7%0.152% 5/28/2025 GK Wealth Management LLC10,452$163K0.2%N/A0.009% 5/19/2025 UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC279,047$4.36M0.0%-0.4%0.234% 5/16/2025 Woodline Partners LP410,000$6.41M0.0%N/A0.344% 5/16/2025 Fred Alger Management LLC36,313$568K0.0%N/A0.030% 5/16/2025 Goldman Sachs Group Inc.1,103,413$17.26M0.0%-15.5%0.926% 5/16/2025 Scientech Research LLC55,205$863K0.2%N/A0.046% 5/16/2025 Millennium Management LLC473,625$7.41M0.0%-79.5%0.397% 5/16/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.71,417$1.12M0.0%+3.0%0.060% 5/16/2025 Cormorant Asset Management LP1,350,000$21.11M1.6%-26.0%1.133% My #1 Pre IPO Trade for 2025 (Ad)SpaceX value has surged to $350 billion... Delivering windfall profits to early investors including Elon Musk and Peter Theil. Right now, you can invest in "the next SpaceX" while its valuation is still below $100 million.Just click here for details inside my free report5/16/2025 AQR Capital Management LLC248,196$3.88M0.0%+21.4%0.208% 5/16/2025 Advisors Asset Management Inc.28,187$441K0.0%+26.2%0.024% 5/16/2025 Allostery Investments LP7,500$117K0.2%N/A0.006% 5/15/2025 PDT Partners LLC317,465$4.97M0.4%-0.7%0.266% 5/15/2025 Graham Capital Management L.P.37,617$588K0.0%+40.2%0.032% 5/15/2025 Quarry LP6,500$102K0.0%-56.7%0.005% 5/15/2025 Paradigm Biocapital Advisors LP1,465,334$22.92M1.1%N/A1.229% 5/15/2025 Driehaus Capital Management LLC1,092,735$17.09M0.2%-0.4%0.917% 5/15/2025 State of Wyoming13,232$207K0.0%+228.5%0.011% 5/15/2025 MYDA Advisors LLC290,000$4.54M0.8%+45.0%0.243% (Data available from 1/1/2016 forward) ARQT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ARQT shares? During the previous two years, 216 institutional investors and hedge funds held shares of Arcutis Biotherapeutics. The most heavily invested institutionals were Suvretta Capital Management LLC ($158.79M), Jennison Associates LLC ($155.75M), Rubric Capital Management LP ($150.71M), Frazier Life Sciences Management L.P. ($138.44M), Vanguard Group Inc. ($106.64M), Polar Capital Holdings Plc ($102.77M), and State Street Corp ($63.47M).Learn more on Arcutis Biotherapeutics' institutional investors. Which institutional investors have been buying Arcutis Biotherapeutics' stock? Of the 185 institutional investors that purchased Arcutis Biotherapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Jennison Associates LLC ($8.65M), Rubric Capital Management LP ($5.37M), Franklin Resources Inc. ($3.36M), Vestal Point Capital LP ($2.70M), Opaleye Management Inc. ($1.96M), Farallon Capital Management LLC ($1.78M), and Point72 Asset Management L.P. ($1.75M). How much institutional buying is happening at Arcutis Biotherapeutics? Institutional investors have bought a total of 24,865,496 shares in the last 24 months. This purchase volume represents approximately $337.52M in transactions. Which of Arcutis Biotherapeutics' major shareholders have been selling company stock? Of the 88 institutional investors that sold Arcutis Biotherapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Millennium Management LLC ($1.84M), Jennison Associates LLC ($1.23M), Invesco Ltd. ($1.23M), Franklin Resources Inc. ($1.16M), J. Goldman & Co LP ($879.57K), Bank of America Corp DE ($639.45K), and Candriam S.C.A. ($636.06K). How much institutional selling is happening at Arcutis Biotherapeutics? Institutional investors have sold a total of 13,675,579 shares in the last 24 months. This volume of shares sold represents approximately $195.68M in transactions. Related Companies LEGN Institutional Ownership RVMD Institutional Ownership RYTM Institutional Ownership RNA Institutional Ownership NUVL Institutional Ownership ABVX Institutional Ownership AXSM Institutional Ownership CRSP Institutional Ownership MRUS Institutional Ownership VKTX Institutional Ownership This page (NASDAQ:ARQT) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arcutis Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arcutis Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access